Ibotta was founded in 2011 by Bryan Leach. According to Bloomberg, in November 2023 Ibotta announced plans for an IPO valued at $2 billion. The company has not officially announced an IPO date, however, there is anticipation for a 2024 IPO.

Ibotta is a mobile software application that offers cashback rewards by enabling online retailer deals to consumers. Per Forge data, Ibotta has raised $92.9 million in funding over 6 rounds, with their latest funding raised on Aug 6, 2019, from a Series D round. Key investors include GGV Capital, Koch Disruptive Technologies, and Teamworthy Ventures.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Register for Details

For more details on financing and valuation of private companies similar to Ibotta before its , register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn More About Ibotta

To invest in Ibotta pre-IPO

Can you invest in Ibotta pre-IPO?

You may invest in Ibotta as it is a public company listed on the NYSE with ticker IBTA. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of Ibotta before it goes public?

You can no longer sell shares of Ibotta on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my Ibotta shares?

Forge can no longer determine the value of Ibotta shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is Ibotta a publicly traded company?

Ibotta became a public company following its IPO on 04/18/2024 and is now traded on the NYSE under the ticker IBTA.

To learn more about Ibotta potential IPO

Will Ibotta go IPO?

Ibotta became a public company following its IPO on 04/18/2024 and is now traded on the NYSE under the ticker IBTA.

What is Ibotta’s IPO price?

The IPO price of Ibotta is not currently available.

When was Ibotta founded?

Ibotta was founded in 2011.

What is Ibotta funding to date?

Ibotta has raised $486.44MM to date.

Who are Ibotta’s major investors?

GGV Capital
Kleiner Perkins
Koch Disruptive Technologies
FJ Labs

Ibotta Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
08/06/2019 Series D $150MM $xx.xx $1B Koch Disruptive Technologies
Price per Share
$xx.xx
Shares Outstanding
4,151,214
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Koch Disruptive Technologies
07/25/2017 Series C-1 $24.98MM $xx.xx $345.4MM Fj Labs, Ggv Capital, Harbor Spring Capital, James Clark, Teamworthy Ventures, Thomas Jermoluk
Price per Share
$xx.xx
Shares Outstanding
1,578,552
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Fj Labs, Ggv Capital, Harbor Spring Capital, James Clark, Teamworthy Ventures, Thomas Jermoluk
10/01/2015 Series C $38.32MM $xx.xx $243.1MM Jim Clark
Price per Share
$xx.xx
Shares Outstanding
3,300,548
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Jim Clark
06/17/2014 Series B $20MM $xx.xx $95.48MM Cbshealthwatch, Greak Oaks Venture Capital, Jim Clark
Price per Share
$xx.xx
Shares Outstanding
3,824,091
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cbshealthwatch, Greak Oaks Venture Capital, Jim Clark
05/02/2013 Series A $8.14MM $xx.xx $51.44MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
1,984,186
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
03/15/2012 Series Seed $1.78MM $xx.xx $5.09MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
2,407,363
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
Updated on: Dec 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.